Fenofibrate

BreastfeedingGeriatricPediatric
  • TRADE NAMES: Apo-Fenofibrate; Tricor (AbbVie)
  • INDICATIONS: Hyperlipidemia
  • CLASS: Fibrate, Lipid regulator
  • HALF-LIFE: 20 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Atorvastatin, Colchicine, Dicumarol, Ezetimibe, Lovastatin, Nicotinic acid, Rosuvastatin, Statins, Warfarin

PREGNANCY CATEGORY: C

Our database has 31 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
CARDIOVASCULAR
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
HEMATOLOGIC
NEUROMUSCULAR/SKELETAL
RENAL
RESPIRATORY
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top